![]() |
市場調查報告書
商品編碼
1549423
IoT醫療設備的全球市場的評估:各產品類型,各連接技術,各終端用戶,各地區,機會,預測(2017年~2031年)IoT Medical Devices Market Assessment, By Product, By Type, By Connectivity Technology, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球物聯網醫療設備市場規模預計將從 2023 年的 396.8 億美元增至 2031 年的 1,385.7 億美元,2024-2031 年預測期內複合年增長率為 16.92%。這種成長是由幾個關鍵因素推動的,包括提高醫療數據準確性和可靠性的感測器技術的快速發展。 5G 和改進的無線網路等連接進步促進了設備之間的無縫資料傳輸和即時通訊。此外,先進的數據分析將改變患者資訊的處理和使用,從而帶來更個人化和有效的治療。
物聯網醫療設備可讓醫生持續監測患者的健康狀況(例如心率和血糖水平),在改善醫療保健方面發揮重要作用。感測器和數據分析的進步可以提高診斷準確性並在健康問題變得嚴重之前預防它們。這些支援遠距醫療和遠端監控,從而在服務不足的地區提供更好的醫療服務。此外,資料收集的自動化將加速醫療保健服務的提供,從而提高效率並節省成本。物聯網設備還透過部署的傳感器發出的即時警報支援即時緊急響應,從而有助於患者安全。
此外,不斷增加的投資和積極的政府措施正在推動全球物聯網醫療設備市場的成長。例如,2024 年 4 月,印度理工學院馬德拉斯分校為聯合國 SG3 "健康與福祉" 營運了印度首個行動醫療設備校準設施。這有望提高救生醫療設備的準確性,並進一步強調物聯網解決方案的重要性。這一趨勢預計將推動這些融合解決方案的發展勢頭並迅速擴大其市場,從而實現更好的患者護理、改善健康結果並透過數據修改效率降低醫療成本。
越來越多地採用遠距醫療和遠距患者監護
遠距醫療和遠距患者監護的興起主要是由物聯網醫療設備市場的無縫發展和有利的政府指令所推動的。先進的基因檢測和複雜的遠端監控服務等最新進展也改善了患者護理和管理。研究經費和支持法規等政府計畫對於促進這些發展至關重要。此外,對疾病預防和長期疾病管理的日益重視也增加了對這些技術的需求。患者使用數位健康工具的意願不斷增強,進一步推動了這些技術的採用。
例如,Rudolf Riester GmbH 將在 2024 年 1 月透過 DocsinClouds 提供第一個完整的遠距醫療解決方案。此遠距醫療解決方案旨在整合各種醫療設備,確保各種臨床和遠距醫療場景的靈活性和效率。這些措施實現了遠端諮詢和患者監測,確保為患者提供優質護理,不受地理障礙。
慢性病流行推動市場成長
慢性病的流行是物聯網醫療設備市場成長的主要驅動力。物聯網提供了一個機會,可以準確監測糖尿病、高血壓和心血管疾病等患者的病情。生理監測系統可以實現持續的即時數據收集和遠端患者跟?,改善併發症的早期檢測、長期參數趨勢、更及時的治療幹預以及更少的治療相關副作用,從而獲得更有利的結果。例如,世界衛生組織(WHO)《中國老化與健康國別評估報告》顯示,中國60歲以上老年人罹患高血壓、糖尿病、中風、癌症、高膽固醇血症等慢性非傳染性疾病的人數不斷增加。報告進一步預測,2040年,老年人口比例將增加至28%。
本報告研究和分析了全球物聯網醫療設備市場,提供市場規模和預測、市場動態以及主要參與者的現狀和前景。
The global IoT medical devices market is projected to witness a CAGR of 16.92% during the forecast period 2024-2031, growing from USD 39.68 billion in 2023 to USD 138.57 billion in 2031. This growth is propelled by several key factors, including the rapid evolution of sensor technology, which enhances the precision and reliability of medical data. Advances in connectivity, such as 5G and improved wireless networks, facilitate seamless data transfer and real-time communication between devices. Additionally, sophisticated data analytics transform patient information processing and utilization, leading to more personalized and effective care.
Internet of Things (IoT) medical devices play a key role in improving healthcare by allowing doctors to monitor patients' health continuously, like their heart rate and blood sugar levels This is crucial for managing chronic diseases, allowing for timely interventions and personalized treatment plans. With the advancements in sensors and data analytics, there is a higher precision of diagnosis as well as prevention against health issues before they escalate. These can support telemedicine and remote monitoring leading to better healthcare delivery in underserved areas. Moreover, it tends to boost healthcare delivery through data collection automation which pays off with higher efficiency and reduced cost. IoT devices also contribute to patient safety, as they aid in real-time alerts from deployed sensors for immediate emergency responses.
In addition, the increasing investments and favorable government initiatives are driving the growth of the global IoT medical devices market. For instance, In April 2024, IIT Madras ran India's first mobile medical devices calibration facility for UN SG3- health and well-being. This is expected to improve the accuracy of life-saving medical devices, further underscoring the importance of IoT solutions. This trend will increase traction and rapid market expansion for these converging solutions that enable better patient care, improve health outcomes, and reduce healthcare costs on data Change efficiencies.
Growing Adoption of Telemedicine and Remote Patient Monitoring
The rise of telemedicine and remote patient monitoring is primarily fueled by the seamless progress witnessed in an IoT medical devices market accompanied by favorable government mandates. Recent advancements, like advanced genetic testing and sophisticated remote monitoring services, also improve patient care and management. Government programs, such as research funding and supportive rules, are crucial in facilitating these developments. Additionally, the growing emphasis on preventing illness and managing long-term diseases has increased the demand for these technologies. This growing willingness of patients to use digital health tools further boosts the adoption of these technologies.
For instance, in January 2024, Rudolf Riester GmbH brings the first complete Telemedicine solution with DocsinClouds. The Telemedicine solution is designed to integrate a diverse range of medical devices, ensuring flexibility and efficiency in various clinical and remote care scenarios. These measures, which allow remote consultations and patient monitoring are an assurance that high-quality care is being given to patients irrespective of geographical barriers.
Increasing Prevalence of Chronic Diseases Drive Market Growth
Increasing incidence of chronic diseases acts as a major driver for the growth of IoT medical devices market. IoT provides an opportunity to enter the door for diseases such as diabetes, hypertension, and cardiovascular disease with accurate monitoring of patient condition). Physiologic monitoring systems allow continuous real-time data collection and remote patient tracking to improve early complication detection, long-term parameter trending, and more timely therapeutic intervention which has led to more desirable outcomes with less treatment-related side effects. For instance, as per World Health Organization's (WHO) China Country Assessment Report on Aging and Health, the population in China aged above 60 in China who have chronic non-communicable diseases, such as hypertension, diabetes, stroke cancer, or/ hypercholesterolemia will grow by a minimum average of 40% reaching at least up to year 2030. The report further stated that the proportion of the geriatric population is anticipated to increase to 28% by 2040.
Wearable Medical Devices Have a Pivotal Role in the Global IoT Market
The growth of wearable medical devices in the IoT medical device market is attributable to advancements in technology and increasing health awareness among consumers, along with growing prevalence & incidence rates for chronic diseases as well as rising market opportunities. Additionally, new technologies like AI & 5G being employed in wearables make the data transmitting and real-time health monitoring operation seamless at one end but on the other side is offering a proactive healthcare paradigm more often required for the present generation of young adults which is quite motivated to be healthy, thus fuelling a bullish run over adoption part.
For instance, in January 2024, Abbott introduced Lingo in the United Kingdom a novel wearable technology with app functionality that provides real-time glucose tracking. It gives users special advice and support to help them get healthier, sleep better, feel happier, stay focused, have more energy, and control their cravings more easily.
North America to Hold Major Share of Global IoT Medical Devices Market
North America dominates the global market for IoT medical devices as broad adoption of smartphones and mobile platforms among the North American population is likely to lead towards continued progress in wearable & remote patient monitoring services, and increased desire for its implementation of Electronic Health Records (EHRs). Government programs that foster digital health further support this area. The trend for increasing adoption of self-operated eHealth platforms due to the lesser doctor-to-patient ratio at various places provides an opportunity for market expansion. All these factors, including technology improvements, market needs, and supportive systems, make North America a major player in the global IoT medical devices landscape. In February 2024, KORE Wireless Group and Medical Guardian LLC announced that they had entered a partnership to bring an e-SIM-enabled medical alert device to market. This innovative solution addresses cell signal issues and healthcare access gaps by allowing electronic carrier switching for continuous 24/7 connectivity.
Future Market Scenario (2024-2031F)
The demand for IoT medical devices is anticipated to rise as healthcare systems increasingly rely on real-time monitoring and early detection of diseases to enhance patient care. These systems minimize human error and automate the process of capturing data, thereby providing more precise information in real-time. In addition, when this is enriched by greater data insights it significantly eases clinician decision-making. This transition allows better care coordination and early interventions, ultimately promoting improved health outcomes while at the same time making healthcare delivery a more efficient process. World Patient Safety Day is an example of this focus, working to enhance the safety and quality culture.
Key Players Landscape and Outlook
The global IoT medical devices market is competitive, with a major number of players at local levels. Regulatory approvals of company products, mergers and acquisitions, and collaborations are the most common market strategies that have been observed in recent times.
In January 2024, GE HealthCare Technologies Inc. announced its agreement to acquire MIM Software Inc., a prominent provider of medical imaging analysis and artificial intelligence (AI) solutions for radiation oncology, molecular radiotherapy, diagnostic imaging, and urology. GE Healthcare Technologies Inc. plans to integrate MIM software's advanced imaging analytics and digital workflow capabilities to accelerate innovation and enhance its solutions across various care areas, ultimately benefiting patients and healthcare systems worldwide.
In May 2023, Medtronic plc, a global leader in healthcare technology, announced that it has entered into definitive agreements to acquire EOFlow Co. Ltd, the manufacturer of the EOPatch - a tubeless, wearable, and fully disposable insulin delivery device. By integrating EOFlow's technology with Medtronic's Meal Detection Technology algorithm and next-generation continuous glucose monitor (CGM), the company aims to enhance its ability to meet the diverse needs of individuals with diabetes, regardless of their treatment stage or insulin delivery preferences.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.